申请人:Pfizer, Inc.
公开号:US06720336B2
公开(公告)日:2004-04-13
The present invention relates to compounds of the formula I,
wherein Z1, Z2, R1, R2 and R3 are defined as in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurological and gastrointestinal disorders.
本发明涉及公式I的化合物,其中Z1,Z2,R1,R2和R3如规范中所定义,含有这种化合物的制药组合物,使用这种化合物治疗神经和胃肠疾病。